NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

Project description

New drugs that overcome antibiotic resistance may be headed for clinical trials

Gram-negative bacteria have an external membrane that prevents antibiotics from penetrating. Increasing multi-drug resistance in Gram-negative bacteria is becoming a major public health challenge and the EU-funded GNA NOW project is rising to meet it. As part of the EU's new Antimicrobial Resistance Accelerator (AMR) Programme, academic and industry experts plan to discover and test the most promising antibiotic compounds over the next six years and bring a handful of them to clinical trials.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• natural sciences › biological sciences › microbiology › bacteriology
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance › antibiotic resistance

Programme(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
• H2020-EU.3.1.7. - Innovative Medicines Initiative 2 (IMI2)

Topic(s)

• IMI2-2018-16-07 - Intravenous treatments of serious infections (urinary tract infections, intra-abdominal infections & hospital-acquired pneumonia/ventilator associated pneumonia) caused by Gram(-) bacteria (Enterobacteriaceae +/- Pseudomonas and/or Acinetobacter)

Call for proposal

H2020-JTI-IMI2-2018-16-single-stage
See other projects for this call

Funding Scheme

IMI2-RIA - Research and Innovation action

Coordinator

STICHTING LYGATURE

Address

Jaarbeursplein 6
3521 AL Utrecht
Netherlands

Activity type

Other

EU contribution

€ 620 681,25

Participants (10)

EVOTEC INTERNATIONAL GMBH

Germany

EU contribution

€ 0

Address

Essener Bogen 7
22419 Hamburg

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

NOSOPHARM

France

EU contribution

€ 4 069 500

Address

21 Avenue Georges-pompidou, Immeuble Danica B
69486 Lyon Cedex 03

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE

France

EU contribution

€ 308 896,25

Address

40 Avenue Tony Garnier
69007 Lyon

Activity type

Research Organisations

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Germany

EU contribution

€ 1 268 750

Address

Inhoffenstrasse 7
38124 Braunschweig

Activity type

Research Organisations

NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST

United Kingdom

EU contribution

€ 2 422 556,25

Address

Southmead Hospital, Southmead Road, Westbury On Trym
BS10 5NB Bristol

Activity type

Research Organisations

THE UNIVERSITY OF LIVERPOOL

United Kingdom

EU contribution

€ 430 523,75

Address

Brownlow Hill 765 Foundation Building
L69 7ZX Liverpool

Activity type

Higher or Secondary Education Establishments

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU contribution

€ 185 662,50

Address

Rue De Tolbiac 101
75654 Paris

Activity type

Research Organisations

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU contribution

€ 1 198 125

Address

Dr Molewaterplein 40
3015 GD Rotterdam

Activity type

Higher or Secondary Education Establishments

MEDIZINISCHE UNIVERSITAET WIEN

Austria

EU contribution

€ 1 495 300

Address

Spitalgasse 23
1090 Wien

Activity type

Higher or Secondary Education Establishments

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU contribution

€ 300 000

Address

Hansastrasse 27C
80686 Munchen

Activity type

Research Organisations